US Map / Arizona
State AZ

Clinical Trials in Arizona

Arizona is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Arizona and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 242 actively recruiting studies with Arizona sites out of 242 registered in total. The busiest research areas in Arizona are Solid Tumor, Prostate Cancer, Obesity. Leading sponsors running trials in the state include Mayo Clinic, University of Arizona, AstraZeneca. By stage, Arizona trials break down as Phase 1 (37), Phase 2 (77), Phase 3 (80), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
242
Recruiting Now
242
← Back to US Map
Top Conditions in Arizona
Solid Tumor (6)Prostate Cancer (6)Obesity (6)Colorectal Cancer (4)Multiple Myeloma (3)Cancer (3)Advanced Solid Tumor (3)Developmental Language Disorder (3)Overweight (3)Colorectal Neoplasms (3)Carcinoma, Non-Small-Cell Lung (3)Graves' Disease (3)

Frequently Asked Questions — Clinical Trials in Arizona

How many clinical trials are currently recruiting in Arizona?
ClinicalMetric currently tracks 242 actively recruiting clinical trials with at least one location in Arizona. The total number of registered studies—including active but not currently enrolling trials—is 242. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Arizona?
Arizona hosts clinical trials across a broad range of medical conditions, including Solid Tumor, Prostate Cancer, Obesity, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Arizona serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Arizona?
To join a clinical trial in Arizona, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Arizona maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Arizona

NCT06639074 Phase 2
Recruiting
Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of P...
Condition
Advanced Fallopian Tube Carcinoma
Enrollment
78 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT05878717 Phase 2, Phase 3
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosi...
Condition
Systemic Sclerosis Associated Interstitial Lung Disease
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
View Trial →
NCT06328608 Phase 2, Phase 3
Recruiting
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Child...
Condition
Fabry Disease
Enrollment
22 pts
Location
United States, Austria, France
Sponsor
Chiesi Farmaceutici S.p.A.
View Trial →
NCT06131840 Phase 1
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Condition
Colorectal Neoplasms
Enrollment
914 pts
Location
United States, Canada, China
Sponsor
Seagen, a wholly owned subsidi
View Trial →
NCT03954574 N/A
Recruiting
Pulmonary Hemodynamics During Exercise - Research Network
Condition
Pulmonary Circulation Diseases
Enrollment
1,500 pts
Location
United States, Australia, Austria
Sponsor
Medical University of Graz
View Trial →
NCT07362017 Phase 3
Recruiting
Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate...
Condition
Moderate-to-severe Chronic Plaque Psoriasis
Enrollment
300 pts
Location
United States
Sponsor
Vanda Pharmaceuticals
View Trial →
NCT07645287 Phase 2
Recruiting
A Study of GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologica...
Condition
HIV-1-infection
Enrollment
175 pts
Location
United States, Australia, Canada
Sponsor
Gilead Sciences
View Trial →
NCT07776678 N/A
Recruiting
Redefining Evaluation of Adiposity and Leanness: Broadening Objective Diagnostic...
Condition
Obesity & Overweight
Enrollment
300 pts
Location
United States
Sponsor
Foundation for the National In
View Trial →
NCT05462106 Phase 1, Phase 2
Recruiting
A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down S...
Condition
Amyloid Plaque
Enrollment
304 pts
Location
United States, Spain, United Kingdom
Sponsor
AC Immune SA
View Trial →
NCT07226661 Phase 2
Recruiting
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
Condition
Major Depressive Disorder (MDD)
Enrollment
230 pts
Location
United States
Sponsor
Supernus Pharmaceuticals, Inc.
View Trial →
NCT04427384 N/A
Recruiting
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Condition
Brain Tumor, Recurrent
Enrollment
600 pts
Location
United States
Sponsor
GT Medical Technologies, Inc.
View Trial →
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
View Trial →
NCT07037459 Phase 3
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejecti...
Condition
Heart Failure With Preserved Ejection Fraction
Enrollment
5,056 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
View Trial →
NCT05338697 N/A
Recruiting
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future...
Condition
Stroke
Enrollment
657 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT06959524 N/A
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Co...
Condition
Coronary Arterial Disease (CAD)
Enrollment
1,616 pts
Location
United States, Australia, China
Sponsor
Boston Scientific Corporation
View Trial →
NCT05484973 N/A
Recruiting
Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Preve...
Condition
Alopecia
Enrollment
99 pts
Location
United States
Sponsor
Cooler Heads Care Inc.
View Trial →
NCT06001827 N/A
Recruiting
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
Condition
Chronic Kidney Diseases
Enrollment
600 pts
Location
United States
Sponsor
VenoStent
View Trial →
NCT06526741 N/A
Recruiting
ASF Alport Patient Registry
Condition
Alport Syndrome
Enrollment
2,500 pts
Location
United States
Sponsor
Alport Syndrome Foundation
View Trial →
NCT06511141 N/A
Recruiting
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Condition
Overactive Bladder
Enrollment
150 pts
Location
United States
Sponsor
Axonics, Inc.
View Trial →
NCT03876054 N/A
Recruiting
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Condition
Chronic Pain
Enrollment
2,000 pts
Location
United States, Australia, Belgium
Sponsor
Abbott Medical Devices
View Trial →
NCT03486873 Phase 3
Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tum...
Condition
Solid Tumors
Enrollment
3,500 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06847061 N/A
Recruiting
Pulmonary Rehabilitation for Rural Patients With COPD
Condition
Chronic Obstructive Pulmonary Disease (COPD
Enrollment
306 pts
Location
United States
Sponsor
Mayo Clinic
View Trial →
NCT06850805 Phase 3
Recruiting
Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adole...
Condition
Chronic Rhinosinusitis Without Nasal Polyps
Enrollment
84 pts
Location
United States
Sponsor
Optinose US Inc.
View Trial →
NCT04557462 Phase 3
Recruiting
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerabi...
Condition
Primary IgA Nephropathy
Enrollment
540 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
View Trial →
Page 5 of 10 — 242 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology